Navigation Links
Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
Date:4/7/2008

single-dose, randomised, double-blind, two-way crossover trial and used an active control. The trial involved 36 patients and was carried out by Prof. Bernd Jilma, MD, of the Medical University of Vienna (Department of Clinical Pharmacology).

The trial confirms data from the Indian market, where Neukine has been approved for therapy since 2004. Mani Iyer, Director IBPL, explains: "Over 3,000 cancer patients have already been treated with Neukine in India. No severe adverse reactions were reported, other than those commonly associated with Filgrastim. We are very confident that our joint clinical trials with Kwizda Pharma will demonstrate the quality of Neukine to the European authorities."

Logistics & Products

IBPL operates an EMEA-certified manufacturing facility in India since March 2007 and is now due to launch its products on the European market. As part of its business strategy, IBPL is working with Kwizda Pharma, which is helping to secure EU approval and will provide support with marketing logistics. Kwizda Pharma (established 1853), which has a well-established clinical background and extensive experience with regulatory procedures, is now offering its expertise to companies that manufacture biosimilar products, particularly those based in India.

Dr. Richard A Kwizda on the future prospects of this approach: "India has an excellent R&D basis and a skilled workforce, which makes its biosimilars attractive products for the European market. Our company supports Indian-based manufacturers of biosimilars to secure approval for the European market in a timely and cost-efficient manner."

About Kwizda GmbH

Kwizda GmbH is a privately owned group of companies and has been operating since 1853 (pharmaceutical division). Kwizda Pharma is a leading Austrian manufacturer and wholesaler of proprietary, in-licensed and third-party pharmaceuticals, OTC drugs and hospital infusions. In 2007, the company recorded sales of approximately
'/>"/>

SOURCE Kwizda Pharma GmbH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
2. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
3. Increasing Dairy Milk Production with Electrolyzed Drinking Water
4. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
5. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
6. ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line
7. On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
8. Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501
9. Data Demonstrate that Obagi Medical Products Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures
10. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
11. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... EMERYVILLE, Calif. , Sept. 17, 2014 /PRNewswire/ ... newest data analytics solution that brings complete visibility ... minimize risks in an ever-evolving reimbursement landscape. Powered ... Integrity brings transparency to the critical point between ... operations impact revenue. The solution will improve revenue ...
(Date:9/17/2014)... MADISON, Tenn. , Sept. 17, 2014 ... be; these infections are not only uncomfortable, they,re often ... best-laid social plans. pH-D Feminine Health Support ( http://ph-defense.com ... vaginal health. It is an all-natural, homeopathic product. ... the most common symptoms of vaginal infection. In many ...
(Date:9/17/2014)... , Sept. 17, 2014  Aratana Therapeutics, Inc. ... company focused on licensing, developing and commercializing innovative ... pricing of its public offering of 4,500,000 shares of its ... of $9.25 per share. Aratana has granted the ... an additional 675,000 shares of its common stock. ...
Breaking Medicine Technology:MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3New Product from Vireo Systems: pH-D Feminine Health Support 2Aratana Therapeutics, Inc. Announces Pricing of Public Offering 2
... DELAND, Fla., May 13 USHIFU, LLC, the clinical ... pleased,to announce conditional written approval pending minor changes to ... for the treatment of,recurrent prostate cancer with the Sonablate(R) ... Dr. Herbert Lepor, Chairman of Urology at NYU ...
... Products Expand Infection Prevention Business, DUBLIN, Ohio, ... products and services that improve the safety and,productivity ... the,acquisition of assets of privately held Enturia, Inc., ... ChloraPrep(R) brand name., ChloraPrep(R) brand products are ...
Cached Medicine Technology:FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer 2Cardinal Health Completes Enturia Acquisition 2
(Date:9/17/2014)... (PRWEB) September 17, 2014 Wright ... Conserve line of metal-on-metal hip replacements continue to ... U.S. District Court, Northern District of Georgia, Bernstein ... List issued by the U.S. Judicial Panel on ... 397 product liability claims have been filed in ...
(Date:9/17/2014)... TX (PRWEB) September 17, 2014 Smart ... Editor’s Picks by Progressive Grocer, a leading trade magazine ... was awarded for originality and flavor, among other attributes. ... as an Editor’s Pick in the September print issue ... Grocer website. , The pizza won based on its ...
(Date:9/17/2014)... Suwanee, GA (PRWEB) September 17, 2014 ... proud to announce the launch of its new vegan ... mask is extremely effective and provided the results skincare ... was to create a gentle yet active mask that ... CEO Lake Louise.” , This Sugar Cane Fruit Mask ...
(Date:9/17/2014)... -- Present-day Europeans are the descendants of at ... a new study. Previous research suggested ... European farmers. But, a new genetic analysis involving ... descendants of Ancient North Eurasians. Nearly all present-day ... group, researchers from Harvard Medical School said. , ...
(Date:9/17/2014)... HealthDay Reporter WEDNESDAY, ... who turn to artificial sweeteners to soothe their sweet ... new Israeli study suggests. Artificial sweeteners can potentially ... researchers found in human and mouse studies. That,s ... bacteria residing in the intestines in ways that can ...
Breaking Medicine News(10 mins):Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 3Health News:Smart Flour Foods Wins 2014 Progressive Grocer Editor’s Pick Award 2Health News:EcoBeauty Brand Lotus Moon Unveils New Gluten-Free Sugar Cane Fruit Mask 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 3Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 2Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 3
... in what triggers jealousy in men and women, study finds ... in the eye of the beholder, a new study suggests. ... to men while emotional infidelity may be of greater concern ... experiences in previous relationships may be even more important. , ...
... notes bloating, stomach pain, fatigue also point to less ... Relying on symptoms alone to identify women who have ... early, a new study indicates. , Research shows that ... healthy women to report symptoms such as abdominal pain, ...
... Jan. 28 Baylor Sammons Breast Center at ... has been recognized by the National Accreditation Program for Breast ... every significant advantage in their battle against breast disease." The ... NAPBC. Accreditation by the NAPBC is only given to those ...
... , ST. PAUL, Minn. , Jan. 28 ... -based Campbell Mithun, has been named Event Chair for this year’s ... Minnesota’s only nonprofit organization to supply life-saving blood and blood components ... to have Jeff Naughtin on board to head this ...
... , TORRANCE, Calif. , Jan. 28 ... is often a renewed focus on personal health and nutrition. ... year are prebiotics and immune health. This is welcome news ... addresses both categories. , SPINS, the leading provider of ...
... past or future, study finds , THURSDAY, Jan. 28 (HealthDay ... look toward the future, their body language reflects their sense ... the University of Aberdeen fitted subjects with motion sensors and ... past. The bodies of those who thought about the future ...
Cached Medicine News:Health News:Personal History Linked to Feelings of Betrayal 2Health News:Symptoms Alone Don't Spot Ovarian Cancer Early 2Health News:Symptoms Alone Don't Spot Ovarian Cancer Early 3Health News:Breast Center at Baylor Dallas Recognized for Commitment to Fighting Breast Disease 2Health News:Breast Center at Baylor Dallas Recognized for Commitment to Fighting Breast Disease 3Health News:Memorial Blood Centers Names Campbell Mithun’s Jeff Naughtin Event Chair for What’s Your Type? Benefit 2Health News:Memorial Blood Centers Names Campbell Mithun’s Jeff Naughtin Event Chair for What’s Your Type? Benefit 3Health News:Sun Chlorella USA Positioned for Strong 2010 2
... Digital Wide Field Lens combines ... high magnification. The enhanced double ... provide high resolution stereo views ... reflections. These unique features make ...
... Stereo Fundus Lens is specifically designed for ... retina. Its enhanced 3-D stereoscopic design enables ... detail, making it ideal for detecting changes ... serous detachments and other macular abnormalities. It ...
The Pan Retinal® 2.2 uniquely combines magnification nearly that of the 20D lens with a field of view approaching that of the 30D lens. Excellent for virtually every examination procedure, includ...
... Volks state-of-the-art 20D diagnostic/laser lens ... astigmatic aberrations and coma delivering ... 20 diopter lens on the market. ... maintains linear image magnification and perfect ...
Medicine Products: